Funding

 





The study is being conducted at the University Hospital Tuebingen and supported by the DZNE (German Centre for Neurodegenerative Diseases) and HIH (Hertie Institute for Clinical Brain Research). Additional third-party fundings have been granted from CIN (Centre for Integrative Neuroscience). A sub-study is supported by TEVA Pharmaceutical Industries Ltd. Further sponsors of TREND are ucb and Janssen Pharmaceuticals, Inc. as well as the International Parkinson Fonds.